Lumipulse: Novel antigen test for quantifying SARS-CoV-2 in saliva

It is simple, rapid, and more conducive for mass-screening.

Follow us onFollow Tech Explorist on Google News

Real-time reverse transcription-polymerase chain reaction (real-time RT–PCR) is one of the most accurate laboratory methods for detecting, tracking, and studying the COVID-19 coronavirus. This method requires trained personnel at every step, from collecting nasal swab samples to interpreting the results. Also, the process takes 2-3 days.

As the virus can be transmitted by an infected person before symptoms develop and is even transmitted by asymptomatic individuals, the ability to screen a large number of people quickly is vital to controlling and preventing the spread of the pandemic. Faster methods to detect the SARS-CoV-2 antigens have been developed, but they are not as sensitive as the RT-PCR test.

In 2020, Fujirebio came up with a novel antigen-based kit called Lumipulse® SARS-CoV-2 Ag kit (Lumipulse), which measures the viral antigen in biological samples within 35 minutes.

Now, scientists from the Hokkaido University used the Lumipulse® SARS-CoV-2 Ag kit to detect SARS-CoV-2 in saliva samples. They also accessed the efficiency and accuracy of the test kit as compared to RT-PCR.

They found that the antigen detection kit, used to perform chemiluminescent enzyme immunoassay (CLEIA), can rapidly detect SARS-CoV-2 with good accuracy. The fascinating features of this novel test are: simple, rapid, and more conducive for mass-screening.

The test was performed on 2056 individuals from three cohorts: patients with clinically confirmed COVID-19, individuals who had contacted patients with COVID-19, and individuals tested on arrival at Tokyo and Kansai International Airports. Scientists collected saliva samples from all individuals and performed RT-PCR tests as well as CLEIA using Lumipulse.

By comparing the results, scientists determined the usefulness of CLEIA. CELIA shows the test results within an hour.

Combined CLEIA and RT-PCR testing on saliva samples have already been implemented at Japanese airport quarantines. The authors recommend adopting it at a broader scale to rapidly screen for SARS-CoV-2.

Journal Reference:
  1. Isao Yokota, et al. A novel strategy for SARS-CoV-2 mass-screening using quantitative antigen testing of saliva: a diagnostic accuracy study. The Lancet Microbe. May 19, 2021. DOI: 10.1016/S2666-5247(21)00092-6
Up next

Managing physical and cognitive impairments in post-COVID-19 syndrome

Symptoms of post-COVID-19 syndrome changed little for nearly 1,000 individuals in their second year.

A new way to identify more infectious variants

System to auto-detect new variants will inform better response to future infectious disease outbreaks.
Recommended Books
The Cambridge Handbook of the Law, Policy, and Regulation for Human–Robot Interaction (Cambridge Law Handbooks)

The Cambridge Handbook of the Law, Policy, and Regulation for Human-Robot...

Book By
Cambridge University Press
Picks for you

Pregnancy complications put sister of women at increased risk of cardiovascular...

Firstborn child most likely to experience adversity during first 3 years

Heavy drinkers with depression experience the same buzz as those without...

Breakthrough: Hydrogel injections increase bone density rapidly

Exploring the challenges of exercising in gyms for women